long intergenic non-protein coding RNA 2460Genealiases: []
Q-omics provides the consensus-scored LINC02460 profile across patient tissues and cancer cell-line models. LINC02460 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in OV. Among the 18 cancer types available for tumor–normal comparison, LINC02460 is differentially expressed in 1, with the highest sampling consensus in KIRP. Additionally, LINC02460 RNA expression shows 6,290 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight OV, KIRP, and STAD as cancer lineages where LINC02460 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02460 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02460 survival associations across molecular data types. LINC02460 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02460 RNA expression–survival associations across cancer types. High LINC02460 expression shows unfavorable associations in OV, ACC, ESCA, SKCM, CESC and KIRC. The OV Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify OV as the clearest survival context for LINC02460 RNA expression.
This table summarizes LINC02460 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02460. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02460 shows higher tumor expression in KIRP. The KIRP box plot shows higher LINC02460 RNA expression in tumor versus normal tissue (log2 FC = +0.033, t-test p = .037).
This table shows molecular features associated with LINC02460 in patient tissues and cancer cell lines. In patient samples, LINC02460 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
